Zomig and Device failure - a phase IV clinical study of FDA data

Summary:

Device failure is reported as a side effect among people who take Zomig (zolmitriptan), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Device failure when taking Zomig. It is created by eHealthMe based on reports of 6,908 people who have side effects when taking Zomig from the FDA, and is updated regularly.

What is Zomig?

Zomig has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 7,356 Zomig users. Check the latest studies of Zomig.

What is Device failure?

Device failure is found to be associated with 751 drugs and 761 conditions by eHealthMe. Check the latest studies of Device failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

6,908 people reported to have side effects when taking Zomig.
Among them, 11 people (0.16%) have Device failure.

Among these 11 people:

How long have people been on Zomig when they have Device failure? *

What is the gender of people who have Device failure when taking Zomig? *

female: 100 %
male: 0.0 %

What is the age of people who have Device failure when taking Zomig? *

What are other drugs people take besides Zomig? *

What are other side effects people have besides Device failure? *

Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 9 people, 81.82%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 81.82%
Fall: 9 people, 81.82%
Femur Fracture: 9 people, 81.82%
Sinus Disorder (disease of sinus): 8 people, 72.73%
Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 72.73%
Endometrial Cancer: 8 people, 72.73%
Periodontal Disease (disease that attacks the gum and bone and around the teeth): 8 people, 72.73%
Polyp: 8 people, 72.73%
Polyp Colorectal: 8 people, 72.73%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 9 people, 81.82%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 72.73%
Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 63.64%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 9.09%
Swelling: 1 person, 9.09%
Postmenopause: 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 9.09%
Allergic Rhinitis: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zomig and have Device failure?

- Check whether Device failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zomig:

Zomig (7,356 reports)

Device failure treatments and more:

Device failure (17,275 reports)

Browse all side effects of Zomig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device failure:

Device failure (751 drugs)

Browse all the conditions that are associated with Device failure:

Device failure (761 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan (the active ingredients of Zomig) and Zomig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.